CN Patent

CN111386268B — 一种urat1抑制剂的晶型及其制备方法

Assigned to Dongbao Zixing Hangzhou Biomedical Co ltd · Expires 2022-04-19 · 4y expired

What this patent protects

本发明公开了一种URAT1抑制剂的晶型及其制备方法。

USPTO Abstract

本发明公开了一种URAT1抑制剂的晶型及其制备方法。

Drugs covered by this patent

Aloprim (ALLOPURINOL) · Casper Pharma Llc

Patent Metadata

Patent number: CN111386268B
Jurisdiction: CN
Classification: —
Expires: 2022-04-19
Drug substance claim: No
Drug product claim: No
Assignee: Dongbao Zixing Hangzhou Biomedical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.